3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
4
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Other hematologic neoplasm
1
Head & Neck
1
Gynecologic
1
Conditions
Hemorrhage
1
Hematologic Neoplasms
1
Interventions
fludarabine
5
Cyclophosphamide
5
Azacitidine
4
Cytarabine
3
venetoclax
2
pegylated granulocyte colony-stimulating factor
2
bisantrene
2
Metformin
2
Etoposide
2
Dasatinib
2
Clofarabine
2
Busulfan
2
vosaroxin
1
treosulfan
1
peginterferon alfa-2a
1
nilotinib
1
liposomal amphotericin B
1
fludarabine phosphate
1
defactinib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
cc-486
1
aldesleukin
1
Zinc Sulfate
1
Zinc
1
Vitamin D
1
Urination
1
Tranexamic Acid
1
Thiotepa
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Tranexamic Acid
×
Other hematologic neoplasm
×
Clear all
NCT03136445
2025-10-28
TREATT
NHS Blood and Transplant
Phase 3
Completed
616 enrolled
34 charts